No phaseStatus unknown

Efficacy and Safety of Enavogliflozin as an Add-on Therapy in Patients with Inadequately Controlled Type 2 Diabetes Mellitus and Obesity: Investigator-Initiated Trial

Efficacy and Safety of Enavogliflozin as an Add-on Therapy in Patients with Inadequately Controlled Type 2 Diabetes Mellitus and Obesity: A Randomized, Open-Label, Multicenter, Investigator-Initiated Trial

Sponsor

Kangbuk Samsung Medical Center

Enrolment

210 planned

Conditions

Endocrine, nutritional and metabolic diseases

Interventions

[Study Groups] 1) Intervention Group

Ages

adults, older adults

Registry

KCT0012450

Full record on CRiSSource: WHO ICTRP, processed 24 August 2026